Sulfamethoxazole is metabolized to the hydroxylamine in humans

Cribb, Alastair E, Spielberg, Stephen P·1992·Clinical Pharmacology and Therapeutics
DOI 10.1038/clpt.1992.57

Cited by (175)

Items 101–175 of 175

  1. Role of drug metabolism for breaking tolerance and the localization of drug hypersensitivity
    Jack Uetrecht · 2005 · Toxicology
  2. Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes
    Goldman, Jennifer L, Koen, Yakov M, Rogers, Steven A, Li, Kelin, Leeder, James S, Hanzlik, Robert P · 2016 · Drug Metabolism and Disposition
  3. Review on Biogeochemical Characteristics of Typical Antibiotics in Groundwater in China
    Wenyu Xiao, Xiaobing Zhao, Yanguo Teng, Jin Wu, Tianyi Zhang · 2023 · Sustainability
  4. Molecular mechanisms of adverse drug reactions
    Sidney D. Nelson · 2001 · Current Therapeutic Research
  5. Immunological principles of T-cell-mediated adverse drug reactions in skin
    Dean John Naisbitt, Munir Pirmohamed, B. Kevin Park · 2007 · Expert Opinion on Drug Safety
  6. Deciphering the immune pathomechanism of cutaneous drug reactions
    Werner J. Pichler · 2002 · Allergy
  7. Pharmacokinetics of sulfamethoxazole with its hydroxy metabolites and N4-acetyl-, N1-glucuronide conjugates in healthy human volunteers
    Vree, Tom B., van der Ven, André J.A.M., Koopmans, Peter P., van Ewijk-Beneken Kolmer, Eleonora W.J., Verwey-van Wissen, Corrien P.W.G.M. · 1995 · Clinical Drug Investigation
  8. Sensitization of mice to topically applied drugs: albuterol chlorpheniramine, clonidine and nadolol
    Richard S. Kalish, Jonathan A. Wood, John J. Wille, Agis F. Kydonieus · 1996 · Contact Dermatitis
  9. Suppression of pokeweed mitogen-driven human IgM and IgG responses by the hydroxylamine of sulfamethoxazole
    Margaret E. Sisson, Michael John Rieder, Ingrid A. Bird, Wassim Youssef Almawi · 1997 · International Journal of Immunopharmacology
  10. Proteomic analysis reveals that sulfamethoxazole induces oxidative stress in M. tuberculosis
    Rajesh Sarkar, C. Mdladla, Lubabalo Macingwana, Ray‐Dean Pietersen, Andile H. Ngwane, David L. Tabb, Paul D. van Helden, Ian J. F. Wiid, Bienyameen Baker · 2018 · Tuberculosis
  11. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4 T-cells
    J HOPKINS, Dean John Naisbitt, N HUMPHREYS, Rebecca Jane Dearman, Ian Kimber, B PARK · 2004 · Toxicology
  12. Bioactivation
    Jack Uetrecht · 2003 · Informa Healthcare eBooks
  13. Lessons from drug allergy: Against dogmata
    Werner J. Pichler · 2003 · Current Allergy and Asthma Reports
  14. An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications
    Saurav Ghimire, E Lee Kyung, J. H. Lee, J. W. Kim, W. Kang, E. Kim · 2013 · Journal of Clinical Pharmacy and Therapeutics
  15. Inhibition of cytokine production and interference in IL‐2 receptor‐mediated Jak‐Stat signaling by the hydroxylamine metabolite of sulfamethoxazole
    David A. Hess, Erin F. O'Leary, James Tseryuan Lee, Wassim Youssef Almawi, Joaquı́n Madrenas, Michael John Rieder · 2001 · The FASEB Journal
  16. Acute delirium induced by intravenous trimethoprim–sulfamethoxazole therapy in a patient with the Acquired Immunodeficiency Syndrome
    Alan R. Salkind · 2000 · Human & Experimental Toxicology
  17. Drug‐Induced Liver Disease
    Shivakumar Chitturi, Geoffrey C. Farrell · 2011 · Wiley eBooks
  18. Bioactivation of benzocaine to a methaemoglobin-forming metabolite by rat and human microsomes in vitro
    Michael D. Coleman, Claire H. Taylor · 1997 · Environmental Toxicology and Pharmacology
  19. Pharmacogenetics and blood dyscrasias
    Stephen P. Spielberg · 1996 · European Journal Of Haematology
  20. Drug allergy: relationship between immunogenicity and clinical symptoms
    Werner J. Pichler · 1999 · Allergy
  21. HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells
    Kemi Adeyanju, John Richard Bend, Michael John Rieder, Gregory A. Dekaban · 2018 · Virology Journal
  22. The Hydroxylamine of Sulfamethoxazole Synergizes with FK506 and Cyclosporin A, Inhibiting T-Cell Proliferation
    David A. Hess, Ingrid A. Bird, Wassim Youssef Almawi, Michael John Rieder · 1997 · Journal of Pharmacology and Experimental Therapeutics
  23. Drug-Induced Liver Disease
    Eve A. Roberts · 2007 · Cambridge University Press eBooks
  24. Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
    Hi̇lmi̇ Orhan · 2014 · Current Medicinal Chemistry
  25. Improvement of sulfamethoxazole (SMX) elimination and inhibition of formations of hydroxylamine-SMX and N4-acetyl-SMX by membrane bioreactor systems
    Min‐Hui Tang, Nan Gao, Jiao Zhou, Yan Zhao, Jing‐Sheng Cheng, Wen-Kun Su, Ying‐Jin Yuan · 2018 · Biodegradation
  26. Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites
    Sanderson, Joseph P., Hollis, Frank J., Maggs, James L., Clarke, Stephen E., Naisbitt, Dean J., Park, B. Kevin · 2008 · Drug Metabolism and Disposition
  27. Comprehensive insights into the formation of metabolites of the ghrelin mimetics capromorelin, macimorelin and tabimorelin as potential markers for doping control purposes
    Tobias Lange, Andreas Thomas, Christian Görgens, Martin Bidlingmaier, Katharina Schilbach, Eric Fichant, Philippe Delahaut, Mario Thevis · 2021 · Biomedical Chromatography
  28. Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Drug-induced lupus: Possible mechanisms and their implications for prediction of which new drugs may induce lupus
    Jack Uetrecht · 1996 · Expert Opinion on Investigational Drugs
  29. Quaternary Cu2ZnSnS4 and Cu2ZnSnS4-WS2 composite for enhanced antioxidant, antibacterial, and photocatalyst for degradation of sulfamethoxazole
    Nur Jalal Mondal, Rahul Sonkar, Mridusmita Barman, Mritunjoy Prasad Ghosh, Devasish Chowdhury · 2024 · Journal of Photochemistry and Photobiology A Chemistry
  30. The Effect of Cimetidine on the Formation of Sulfamethoxazole Hydroxylamine in Patients with Human Immunodeficiency Virus
    David F. Lehmann, Nancy B. Newman, Philo Morse · 1998 · The Journal of Clinical Pharmacology
  31. Allergy to antibacterials: the problem with beta-lactams and sulfonamides
    Andreas Cerny, Werner J. Pichler · 1998 · Pharmacoepidemiology and Drug Safety
  32. Towards the development of mechanism-based biomarkers to diagnose drug hypersensitivity
    Noé Durán‐Figueroa, Jesús Agustín Badillo-Corona, Dean John Naisbitt, José Luis Castrejón-Flores · 2015 · Toxicology Research
  33. Assessment of arylamine N‐acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients.
    Alastair E. Cribb, Ban C. H. Tsui, Richard A. Isbrucker, RT Michael, C. T. Gillespie, J Brown‐Bonomo, P Barrett, Terry L. LeVatte, K W Renton · 1995 · British Journal of Clinical Pharmacology
  34. Mécanismes immunologiques des réactions cutanées aux médicaments
    Ewa Poszepczynska-Guigné, Jean E. Revuz, Jean‐Claude Roujeau · 2005 · Annales de Dermatologie et de Vénéréologie
  35. Antibacterial Agents, Sulfonamides
    Michele A. Weidner‐Wells, Mark J. Macielag · 2003 · Wiley eBooks
  36. Adverse reactions to trimethoprim-sulfamethoxazole
    Belle L. Lee · 1996 · Clinical Reviews in Allergy & Immunology
  37. T Cell Responses to Drugs and Drug Metabolites
    Caroline J. Earnshaw, Tatjana Pecaric-Petkovic, B. K. Park, Dean John Naisbitt · 2013 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions
  38. Cytotoxicity testing of β-lactam antibiotics, non-steroidal anti-inflammatory drugs and sulfonamides in primary human keratinocyte cultures
    M. PATOUX-PiBOUIN, Béatrice Hirel, Christophe Chesné, Éric Watier, Jacqueline Chevrant‐Breton, André Guillouzo · 1995 · Toxicology in Vitro
  39. An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions
    Cristobalina Mayorga, Maria Isabel Montañez, Raquel Jurado‐Escobar, Violeta Gil-Ocaña, José Antonio Cornejo-García · 2019 · Current Pharmaceutical Design
  40. Activation of the TCR Complex by Small Chemical Compounds
    Christine Louis-Dit-Sully, Wolfgang W A Schamel · 2013 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions
  41. Improving Drug Design: Considerations for the Structural Modification Process
    Ala F. Nassar · 2010 · Wiley eBooks
  42. Adverse drug reaction monitoring in JenaRelevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions
    Marion Hippius, Christiane Buchardt, Katrin Farker, U KUHN, Ilselore R. Reimann, Andreas Hoffmann · 2003 · Experimental and Toxicologic Pathology
  43. Development and Validation of RP-HPLC Method for Quantitative Analysis of Sulfamethoxazole and Trimethoprim in Liquid Suspension: A Comparative Study with Compendial Method
    Muhammad Aslam, Shahzad M. Ali, Mahmood Ahmed, Muhammad Aneeq Javed, Afsah Iftikhar, Yousaf Abbas, Aamir Sohail, Mehvish Abdul-Rehman, Khansa Habibullah · 2023 · Scientific Inquiry and Review
  44. Insights on aggregation-algae consortium based removal of sulfamethoxazole: Unraveling removal effect, enhanced method and toxicological evaluation
    Yongtao Cheng, Yuanyuan Wu, Chuanyue Peng, Yang Yang, Liang Xuan, Lin Wang, Yan Wang, An Xu, Ying Liu · 2024 · Journal of Environmental Management
  45. Classifying the Transformation Products (TPs) of Emerging Contaminants (ECs) for Prioritizing Research into their Impact on the Environment and Human Health
    Jacek Namieśnik, Lidia Wolska, Radosław Czernych, Grażyna Gałęzowska, Monika Cieszyńska-Semenowicz · 2014 · Wiley eBooks
  46. Chemical Structural Alert and Reactive Metabolite Concept as Applied in Medicinal Chemistry to Minimize the Toxicity of Drug Candidates
    Ala F. Nassar · 2022 · Wiley eBooks
  47. The stress response and removal mechanism of Chlorella vulgaris to sulfamethoxazole
    Chen Liang, Yuanyuan Zhou, Yifei Zhou, Penglan Zhu, Chun-Li Yu, Yali Luo, Jielian Wu, Qingsong Zhou, Wenkui Li, Shanshan Luo · 2025 · Algal Research
  48. Cutaneous drug reactions with systemic features
    Simon Robert Knowles, Neil H. Shear · 2013 · Elsevier eBooks
  49. Populations at risk: Predicting and preventing drug-induced disease
    Stephen P. Spielberg · 1993 · Pharmacoepidemiology and Drug Safety
  50. Pathophysiologic Mechanisms of Immune-mediated Drug Hypersensitivity Reactions to Sulfonamides
    Elham A. Sultan · 2015 · Scholarship@Western (Western University)
  51. Sulfonamide-induced cutaneous drug reactions
    Piyush M. Vyas · 2006
  52. Traitement des effluents d’un service d’oncologie par bioréacteur à membranes : faisabilité d’acclimatation et gain apporté sur l’élimination de molécules médicamenteuses
    Pierre Hamon · 2014 · theses.fr (ABES)
  53. N-Acetyltransferase (NAT) 1 and NAT2 Enzyme Activities Drive Interindividual Variability in Sulfamethoxazole N-Acetylation
    Lanphier, Raeanne M., Latham, Bethany D., Gerringer, Amanda J., Interrante, Tyler, Jones, Corbin D., De Buysscher, Tristan, Fallon, John K., Jackson, Klarissa D. · 2025 · Drug Metabolism and Disposition
  54. Drug hypersensitivity reactions
    M. Blanca, Bernard Yu‐Hor Thong · 2015 · Current Opinion in Allergy and Clinical Immunology
  55. Isoxazole
    Erum Akbar Hussain, Ambreen Ghani, Zubi Sadiq · 2024 · Elsevier eBooks
  56. Adverse drug reaction monitoring in Jena
    Marion Hippius, Christiane Buchardt, Katrin Farker, Urs Dieter Kuhn, Ilselore R. Reimann, Annemarie Hoffmann · 2003 · Experimental and Toxicologic Pathology
  57. Workshop Session: MONDAY, JUNE 3, 1996
    1996 · Allergy
  58. Minimizing the Potential for Drug Bioactivation of Drug Candidates to Success in Clinical Development
    Ala F. Nassar · 2008 · Wiley eBooks
  59. Pediatric Hepatic Drug Reactions
    Eve A. Roberts · 1996 · Handbook of experimental pharmacology
  60. Hypersensitivity Syndrome Reaction
    Simon Robert Knowles, Neil H. Shear · 2010 · Springer eBooks
  61. EFFECT OF COMBINATION EXPOSURE TO ZIDOVUDINE AND SULFAMETHOXAZOLE-TRIMETHOPRIM ON IMMUNE RESPONSE IN MICE AND HUMANS
    David J. Feola · 2005 · UKnowledge (University of Kentucky)
  62. Minimizing the Potential for Drug Bioactivation of Drug Candidates to Success in Clinical Development
    Ala F. Nassar · 2010 · Wiley eBooks
  63. Genetically Determined Polymorphisms in Drug Metabolism
    Y. W. Francis Lam, Milton V. Marshall · 1992 · Journal of Pharmacy Practice
  64. A. Classification of Drug Hepatotoxicity
    Eve A. Roberts · 1996
  65. Role of Microorganisms in Degradation and Removal of Anticonvulsant Drugs: A Review
    Neha Alok Sinha, Vipin Kumar · 2019 · Energy, environment, and sustainability
  66. Cutaneous Drug Reactions With Systemic Features
    Simon Robert Knowles, Lori E. Shapiro, Neil H. Shear · 2020 · Elsevier eBooks
  67. Exvotos inéditos de Despeñaperros en la colección A. Aguirre, de Bilbao
    Carmelo Fernández Ibáñez · 1984 · Boletín del Instituto de Estudios Giennenses
  68. Immunological Mechanisms of Cutaneous Adverse Drug Reactions
    E. Guigné, Jean E. Revuz, Jean‐Claude Roujeau · 2004 · CRC Press eBooks
  69. Drug Reactions
    Hans Friedrich Merk, Daniela Hoeller Obrigkeit · 2010 · Springer eBooks
  70. Drug allergy: relationship between immunogenicity and clinical symptoms
    Werner J. Pichler · 1996 · Allergy
  71. Exanthematic Reactions
    Simon Robert Knowles, Neil H. Shear · 2014
  72. Drug allergy: relationship between immunogenicity and clinical symptoms
    Werner J. Pichler · 1999 · Allergy
  73. Adverse Reactions to Trimethoprim-Sulfamethoxazole
    Belle L. Lee · 1997 · Humana Press eBooks
  74. Clinical Study on Penicillin Anaphylaxis and Role of Oxidative Stress and Pro-inflammatory Markers: An Implication for Therapy
    Showkat Ul Nabi, Abrar Ul Haq, Showkeen Muzamil, Hafiz Antar Makeen, Mohammed Al Bratty, Andleeb Khan · 2022 · Indian Journal of Animal Research
  75. Antibiotic-targeted water treatment with cost-effective bioadsorbents
    Anna Viktória Vancsik · 2024 · Scientia et Securitas